Briggs Morrison
CEO
CEO
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of Research and Development and Former Chief Executive Officer | $637,500 | $2,374,171 |
| 2021 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of Research and Development and Former Chief Executive Officer | $618,563 | $3,904,316 |
| 2020 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of Research and Development and Former Chief Executive Officer | $600,547 | $2,165,397 |
Earnings-call appearances
-
Syndax Pharmaceuticals Inc Q4 FY2022 Earnings Call2023-02-28
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-08
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2022 Earnings Call2022-05-09
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q4 FY2021 Earnings Call2022-03-01
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2021 Earnings Call2021-11-15
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2021 Earnings Call2021-08-09
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-11
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q4 FY2020 Earnings Call2021-03-08
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2020 Earnings Call2020-11-02
Syndax Pharmaceuticals Inc (SNDX)
-
Schneider National, Inc. Q3 FY2020 Earnings Call2020-10-29
Schneider National, Inc. (SNDR)
-
Syndax Pharmaceuticals Inc Q2 FY2020 Earnings Call2020-08-06
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2020 Earnings Call2020-04-30
Syndax Pharmaceuticals Inc (SNDX)